Betta Pharmaceuticals Co., Ltd.(SZ:300558) Zhong Guo Xin Wen Wang·2025-05-01 07:21Core Viewpoint - The article highlights the dedication and contributions of Gao Yaqin, a quality engineer at Betta Pharmaceuticals, who has been instrumental in ensuring the quality of innovative drugs, particularly the first small molecule targeted cancer drug in China, for over fifteen years [1][3]. Group 1: Company Background - Betta Pharmaceuticals was established during a time when generic drugs dominated the market, with a small team focused on developing China's first small molecule targeted anti-cancer drug [3]. - The company successfully launched the drug, Erlotinib Hydrochloride, in 2011, which won the National Science and Technology Progress Award [3]. Group 2: Quality Control Achievements - Gao Yaqin has maintained a 100% accuracy rate in quality inspections over her fifteen-year career, demonstrating exceptional professional skills and experience [6]. - The rigorous quality control processes led to the successful market entry of Erlotinib Hydrochloride, benefiting approximately 700,000 lung cancer patients [6]. Group 3: Problem-Solving and Team Leadership - Gao Yaqin's proactive approach in identifying discrepancies in product data has prevented potential quality issues, showcasing her critical role in the quality assurance process [4]. - She led her team in a thorough investigation to resolve a data anomaly, ensuring that a batch of hundreds of kilograms of medicine was cleared for market release after confirming its quality [6].